3D Medicines (HKSE:01244) Market Cap : HK$1,864.0 Mil (As of May. 16, 2024)

View and export this data going back to 2022. Start your Free Trial

What is 3D Medicines Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 3D Medicines's share price for the quarter that ended in Dec. 2023 was HK$7.64. 3D Medicines's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 258.2 Mil. Therefore, 3D Medicines's market cap for the quarter that ended in Dec. 2023 was HK$1,972.7 Mil.

3D Medicines's quarterly market cap increased from Dec. 2022 (HK$10,864.8 Mil) to Jun. 2023 (HK$24,720.6 Mil) but then declined from Jun. 2023 (HK$24,720.6 Mil) to Dec. 2023 (HK$1,972.7 Mil).

3D Medicines's annual market cap increased from Dec. 2021 (HK$0.0 Mil) to Dec. 2022 (HK$10,864.8 Mil) but then declined from Dec. 2022 (HK$10,864.8 Mil) to Dec. 2023 (HK$1,972.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 3D Medicines's Enterprise Value for Today is HK$1,050.5 Mil.

3D Medicines Market Cap Historical Data

The historical data trend for 3D Medicines's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Medicines Market Cap Chart

3D Medicines Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Market Cap

10,864.79

1,972.70

3D Medicines Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial			-	-	10,864.79	24,720.58	1,972.70

Competitive Comparison of 3D Medicines's Market Cap

For the Biotechnology subindustry, 3D Medicines's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Medicines's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Medicines's Market Cap distribution charts can be found below:

* The bar in red indicates where 3D Medicines's Market Cap falls into.

3D Medicines Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

3D Medicines's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	HK$7.64	*	258.207
	=	HK$1,972.7

3D Medicines's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	HK$7.64	*	258.207
	=	HK$1,972.7

3D Medicines (HKSE:01244) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

3D Medicines Market Cap Related Terms

Thank you for viewing the detailed overview of 3D Medicines's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Medicines (HKSE:01244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Medicines Inc (HKSE:01244) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 and No. 5, Laiyang Road, Shandong, Qingdao, CHN

Website

https://www.3d-medicines.com

3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization of drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life.

3D Medicines (HKSE:01244) Headlines

No Headlines